Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “SARS-CoV-2 (COVID-19) Severe Pneumonia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT05115045
What this trial is testing

Plasma SARS-CoV-2 RNA Levels in Critically Ill COVID-19 Patients

Who this might be right for
COVID-19 PneumoniaARDS Due to Disease Caused by Severe Acute Respiratory Syndrome Coronavirus 2
Hopital of Melun 122
Post-approval studies (Phase 4)Ended earlyNCT04351191
What this trial is testing

PRophylaxis of Exposed COVID-19 Individuals With Mild Symptoms Using choloroquinE Compounds

Who this might be right for
Sars-CoV2Symptomatic ConditionCovid-19
Government of Punjab, Specialized Healthcare and Medical Education Department 137
Large-scale testing (Phase 3)Study completedNCT04518410
What this trial is testing

ACTIV-2: A Study for Outpatients With COVID-19

Who this might be right for
CoronavirusCovid19
National Institute of Allergy and Infectious Diseases (NIAID) 4,044
Large-scale testing (Phase 3)Study completedNCT04883203
What this trial is testing

The Effect of Vitamin D Supplementation on COVID-19 Recovery

Who this might be right for
Covid19
University of Monastir 130
Large-scale testing (Phase 3)Study completedNCT04466241
What this trial is testing

Combination Therapies to Reduce Carriage of SARS-Cov-2 and Improve Outcome of COVID-19 in Ivory Coast: a Phase Randomized IIb Trial

Who this might be right for
COVID-19COVID-19 Drug TreatmentSevere Acute Respiratory Syndrome Coronavirus 2
ANRS, Emerging Infectious Diseases 294
Not applicableUnknownNCT04738331
What this trial is testing

Analysing the French COVID-19 Epidemic Using a National SARS-CoV-2 RT-PCR Database

Who this might be right for
Covid-19SARS-CoV Infection
University Hospital, Montpellier 10,000,000
Early research (Phase 1)Ended earlyNCT04762186
What this trial is testing

Viable Human SARS-CoV-2 Specific T Cell Transfer in Patients at Risk for Severe COVID-19

Who this might be right for
Moderate COVID-19-infection
Universitätsklinikum Köln 1
Testing effectiveness (Phase 2)WithdrawnNCT04561180
What this trial is testing

Study to Evaluate the Efficacy and Safety of EG-009A Compared to DEX in Patients With COVID-19 Pneumonia

Who this might be right for
COVID-19 Pneumonia
Evergreen Therapeutics, Inc.
Not applicableStudy completedNCT06727474
What this trial is testing

Clinical and Functional Characteristics of Patients Admitted for Severe COVID-19 Pneumonia

Who this might be right for
Post-intensive Care SyndromeCOVID-19
Hospital Nacional Profesor Alejandro Posadas 51
Large-scale testing (Phase 3)UnknownNCT05258669
What this trial is testing

Immuno-bridging and Broadening Study of a Whole, Inactivated COVID-19 Vaccine BBV152 in Healthy Adults

Who this might be right for
COVID-19
Ocugen 400
Large-scale testing (Phase 3)WithdrawnNCT04684550
What this trial is testing

Use of Hypochlorous Acid as Prophylaxis in Health Personnel at High Risk of Infection by SARS-CoV 2 (COVID19)

Who this might be right for
SARS-CoV InfectionCovid19Infection Viral
Hospital Universitario San Ignacio
Not applicableStudy completedNCT04376905
What this trial is testing

Extra Vascular Lung Water and Pulmonary Permeability in Critically Ill Patients With SARS-CoV-2 (COVID-19)

Who this might be right for
COVID-19PneumoniaAcute Respiratory Distress Syndrome
University Hospital, Montpellier 30
Post-approval studies (Phase 4)UnknownNCT04377750
What this trial is testing

The Use of Tocilizumab in the Management of Patients Who Have Severe COVID-19 With Suspected Pulmonary Hyperinflammation

Who this might be right for
Covid19 Pneumonia
Hadassah Medical Organization 500
Early research (Phase 1)Study completedNCT04397757
What this trial is testing

COVID-19 Convalescent Plasma for the Treatment of Hospitalized Patients With Pneumonia Caused by SARS-CoV-2.

Who this might be right for
COVID-19
University of Pennsylvania 80
Testing effectiveness (Phase 2)WithdrawnNCT04379492
What this trial is testing

Hydroxycholoroquine Compared to Placebo as Treatment for People With COVID-19

Who this might be right for
COVID-19COVID19Sars-CoV2+1 more
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Ended earlyNCT04391309
What this trial is testing

COVID-19 and Anti-CD14 Treatment Trial

Who this might be right for
Coronavirus Disease 2019 (COVID-19)Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
National Institute of Allergy and Infectious Diseases (NIAID) 49
Large-scale testing (Phase 3)UnknownNCT04391101
What this trial is testing

Convalescent Plasma for the Treatment of Severe SARS-CoV-2 (COVID-19)

Who this might be right for
SARS-Cov-2
Hospital San Vicente Fundación 231
Not applicableStudy completedNCT04838834
What this trial is testing

Monitoring Serologic Response to Severe Acute Respiratory Syndrome-2 (SARS-COV-2)/COVID-19 in Children

Who this might be right for
COVID-19SARS-CoV-2Inflammatory Bowel Diseases
Connecticut Children's Medical Center 472
Not applicableStudy completedNCT04396353
What this trial is testing

EXercise TRAining and Sedentary Lifestyle on Clinical Outcomes in Patients With COVID-19

Who this might be right for
COVID-19SARS-CoV 2Corona Virus Infection+1 more
University of Sao Paulo General Hospital 1,574
Not applicableStudy completedNCT04715607
What this trial is testing

COVID-19: SARS-CoV-2 Detection in Saliva, Oropharyngeal and Nasopharyngeal Specimens

Who this might be right for
SARS-CoV InfectionCovid19Coronavirus
Rigshospitalet, Denmark 27,947
Next Page